middl
east
respiratori
syndrom
coronaviru
merscov
zoonot
betacoronaviru
first
detect
human
caus
sever
acut
respiratori
diseas
juli
confirm
case
report
death
mani
infect
fatal
also
larg
number
mild
asymptomat
case
discov
monitor
contact
trace
new
zealand
white
rabbit
possibl
model
asymptomat
infect
merscov
order
discov
nonleth
infect
learn
whether
singl
infect
merscov
would
protect
reinfect
inocul
rabbit
merscov
monitor
antibodi
inflammatori
respons
follow
intranas
infect
rabbit
develop
transient
dosedepend
pulmonari
infect
moder
high
level
viral
rna
viral
antigen
perivascular
inflamm
multipl
lung
lobe
associ
clinic
sign
rabbit
develop
antibodi
viral
protein
lack
neutral
activ
anim
protect
reinfect
fact
reinfect
result
enhanc
pulmonari
inflamm
without
associ
increas
viral
rna
titer
interestingli
passiv
transfer
serum
previous
infect
rabbit
rabbit
associ
enhanc
inflamm
upon
infect
found
inflamm
accompani
increas
recruit
complement
protein
compar
primari
infect
howev
reinfect
elicit
neutral
antibodi
protect
rabbit
subsequ
viral
challeng
data
rabbit
model
suggest
peopl
expos
merscov
fail
develop
neutral
antibodi
respons
person
whose
neutral
antibodi
titer
wane
may
risk
sever
lung
diseas
reexposur
merscov
plo
pathogen
http
doinew
zealand
white
rabbit
display
increas
lung
inflamm
follow
reinfect
merscov
associ
nonneutr
antibodi
complement
protein
develop
neutral
antibodi
result
protect
infect
find
may
implic
individu
fail
develop
neutral
antibodi
respons
whose
respons
wane
time
upon
reexposur
merscov
enhanc
inflamm
mer
reinfect
rabbit
plo
pathogen
http
august
compet
interest
author
declar
compet
interest
exist
fig
schemat
rabbit
infect
studi
rabbit
inocul
intranas
strain
merscov
green
arrow
tissu
sampl
collect
viral
titrat
histopatholog
necropsi
blue
arrow
three
rabbit
necropsi
time
point
number
indic
day
sinc
viru
administr
primari
secondari
tertiari
infect
enhanc
inflamm
mer
reinfect
rabbit
plo
pathogen
http
august
fig
viral
rna
titer
histopatholog
lung
rabbit
follow
reinfect
merscov
viral
rna
titer
lung
rabbit
follow
reinfect
imag
show
h
e
left
ihc
enhanc
inflamm
mer
reinfect
rabbit
plo
pathogen
http
doi
sinc
discoveri
middl
east
respiratori
syndrom
coronaviru
merscov
caus
least
human
infect
death
worldwid
like
human
coronavirus
merscov
associ
respiratori
tract
infect
howev
unlik
human
coronavirus
merscov
zoonot
origin
caus
sever
ill
result
acut
respiratori
distress
syndrom
characterist
reminisc
sever
acut
respiratori
syndrom
coronaviru
sarscov
caus
larg
outbreak
human
infect
serolog
survey
person
arabian
peninsula
shown
low
undetect
level
preexist
antibodi
merscov
although
close
contact
camel
reservoir
host
merscov
higher
rate
seroposit
gener
popul
longitudin
studi
also
indic
serum
antibodi
titer
may
wane
time
particularli
follow
mild
infect
similar
observ
coronavirus
like
sarscov
sinc
discoveri
merscov
one
autopsi
report
publish
cours
merscov
infect
human
still
well
understood
particularli
true
mild
asymptomat
infect
compris
larg
number
merscov
infect
healthi
adult
wish
explor
immun
respons
nonleth
merscov
infect
determin
whether
infect
would
protect
sever
small
anim
includ
ferret
hamster
mice
frequent
use
anim
model
human
diseas
proven
resist
infect
merscov
dipeptidyl
peptidas
protein
cellular
receptor
merscov
anim
differ
human
key
residu
therefor
bind
merscov
spike
protein
sever
modifi
mous
model
gener
overcom
receptormedi
restrict
includ
transduc
transgen
anim
express
human
lethal
infect
model
establish
nonhuman
primat
success
infect
rhesu
macaqu
display
mild
transient
ill
marmoset
demonstr
sever
sometim
lethal
infect
although
discrep
find
marmoset
camel
alpaca
also
experiment
infect
exhibit
transient
viral
replic
upper
respiratori
tract
howev
expens
care
camel
ethic
concern
surround
use
nonhuman
primat
limit
widespread
util
research
studi
new
zealand
white
rabbit
support
product
replic
merscov
isol
without
associ
clinic
sign
diseas
sought
character
role
antibodi
protect
reinfect
follow
asymptomat
infect
found
primari
infect
fail
induc
neutral
antibodi
reinfect
associ
increas
pulmonari
inflamm
reinfect
elicit
neutral
antibodi
protect
rabbit
subsequ
infect
thu
whilst
neutral
antibodi
protect
may
elicit
may
last
long
mild
infect
merscov
infect
presenc
nonneutr
antibodi
may
associ
enhanc
pulmonari
inflamm
order
studi
initi
diseas
progress
antibodi
respons
associ
mer
cov
infect
rabbit
infect
nine
new
zealand
white
rabbit
either
low
dose
tcid
high
dose
tcid
fig
none
rabbit
display
overt
clinic
sign
ill
day
follow
infect
viral
rna
titer
measur
qrtpcr
use
primer
pair
target
nucleocapsid
protein
report
genom
equival
per
gram
tissu
found
method
sensit
less
variabl
recov
infecti
viru
infect
rabbit
tissu
fig
fig
report
previous
rabbit
merscov
anim
model
observ
transient
infect
follow
inocul
detect
viral
rna
larg
limit
respiratori
tract
nasal
turbin
viral
rna
detect
sporad
although
titer
increas
day
postinfect
gener
higher
dose
viru
result
greater
mean
genom
equival
titer
infect
lower
dose
merscov
fig
doserespons
observ
lower
respiratori
tract
tcid
inoculum
result
significantli
higher
titer
infect
tcid
viru
day
postinfect
fig
p
valu
respect
follow
primari
infect
tcid
mild
inflamm
involv
perivascular
peribronchiolar
alveolar
interstiti
region
observ
lung
day
postinfect
littl
cellular
debri
within
airway
fig
tabl
cellular
infiltr
larg
compos
eosinophil
macrophag
fewer
lymphocyt
plasma
cell
fig
inset
inflamm
observ
follow
infect
tcid
viru
mediaonli
control
fig
tabl
base
blind
score
digit
quantit
analysi
immunohistochemistri
ihc
reveal
viru
antigen
follow
infect
higher
tcid
dose
viru
fig
inset
tabl
lower
dose
mediaonli
inoculum
fig
tabl
separ
experi
rabbit
inocul
tcid
fig
viral
rna
titer
lung
sustain
day
drop
almost
baselin
level
day
undetect
day
postinfect
serum
collect
detect
mersspecif
antibodi
elisa
microneutr
mn
assay
tabl
eight
week
inocul
serum
antibodi
protein
detect
igg
elisa
rabbit
inocul
tcid
geometr
mean
titer
gmt
group
inocul
tcid
antibodi
nucleocapsid
n
protein
detect
igg
elisa
two
rabbit
previous
inocul
tcid
one
rabbit
tcid
howev
neutral
antibodi
detect
rabbit
inocul
dose
tabl
data
indic
doserespons
merscov
infect
rabbit
measur
viral
rna
antibodi
titer
peak
viral
titer
occur
day
postinfect
higher
titer
observ
follow
infect
tcid
viru
sinc
tcid
dose
gave
similar
result
tcid
dose
chosen
remain
studi
neither
anti
antin
protein
antibodi
provid
protect
reinfect
find
rabbit
reminisc
report
human
case
qrtpcr
confirm
infect
merscov
fail
elicit
either
neutral
antibodi
respons
detect
antibodi
respons
viru
order
determin
whether
patient
would
suscept
reinfect
repeat
merscov
infect
previous
infect
rabbit
eight
week
primari
infect
challeng
six
rabbit
previous
receiv
high
low
dose
merscov
tcid
fig
addit
rabbit
inocul
comparison
primari
infect
clinic
sign
observ
upon
reinfect
neither
group
reinfect
rabbit
viral
rna
detect
upper
respiratori
tract
although
viral
rna
detect
primari
infect
control
group
fig
howev
group
evid
pulmonari
infect
rabbit
infect
serial
tcid
lower
viral
rna
titer
compar
tcid
tcid
primari
infect
group
mean
titer
tcid
eq
per
gram
tissu
respect
fig
inflammatori
chang
sever
upon
reinfect
compar
primari
infect
greatest
inflamm
observ
anim
previous
infect
low
dose
viru
fig
tabl
sever
inflam
region
character
abund
eosinophil
macrophag
lymphocyt
plasma
cell
form
dens
cellular
collar
inflammatori
cell
around
affect
perivascular
peribronchiolar
region
addit
cellular
infiltr
expand
obscur
much
adjac
alveolar
interstitium
alveolar
interstitium
also
contain
region
proteinac
fluid
diffus
type
ii
pneumocyt
hyperplasia
fig
inset
inflammatori
respons
driven
reinfect
residu
inflamm
primari
infect
confirm
includ
group
previous
infect
rabbit
receiv
diluent
alon
reinfect
studi
fig
tabl
rabbit
tcid
group
antigen
level
compar
primari
infect
tcid
group
lower
level
antigen
ihc
fig
tabl
data
indic
low
titer
nonneutr
antibodi
protect
rabbit
reinfect
may
instead
result
enhanc
inflamm
proteinspecif
igg
elisa
antibodi
titer
boost
follow
secondari
infect
remain
detect
five
week
gmt
tcid
group
gmt
tcid
group
tabl
n
proteinspecif
antibodi
found
rabbit
tcid
group
one
tcid
group
secondari
infect
group
result
product
neutral
antibodi
although
titer
one
rabbit
tcid
group
drop
detect
limit
five
week
postinfect
tabl
overal
tcid
group
lower
neutral
titer
tcid
group
gmt
respect
determin
neutral
antibodi
would
protect
reinfect
three
rabbit
secondari
infect
group
rechalleng
tcid
five
week
later
fig
clinic
sign
ill
observ
rabbit
observ
second
infect
viral
rna
detect
upper
respiratori
tract
sampl
either
group
rabbit
day
postinfect
lung
signific
decreas
amount
viral
rna
observ
tcid
group
tcid
group
compar
primari
infect
mean
titer
tcid
eq
per
gram
tissu
respect
p
valu
fig
decreas
viral
load
also
observ
ihc
tabl
histolog
lung
group
display
mild
inflamm
minim
antigen
burden
fig
tabl
milder
region
peribronchiolar
perivascular
inflamm
eosinophil
macrophag
predomin
fig
inset
thu
infect
presenc
neutral
antibodi
associ
signific
protect
viral
infect
associ
patholog
upper
lower
respiratori
tract
rabbit
moreov
prechalleng
serum
neutral
antibodi
titer
invers
correl
viral
rna
titer
follow
tertiari
infect
fig
determin
nonneutr
antibodi
respons
enhanc
inflamm
observ
follow
reinfect
perform
passiv
transfer
pt
experi
serum
collect
rabbit
four
week
follow
primari
infect
tcid
transfer
either
undilut
dilut
pb
rabbit
challeng
tcid
viru
follow
day
comparison
group
previous
infect
rabbit
reinfect
although
elisa
antibodi
protein
bare
detect
serum
tabl
serum
concentr
tenfold
prior
administr
elisa
titer
rang
neutral
activ
detect
even
concentr
serum
thu
low
titer
nonneutr
antibodi
present
transfer
serum
passiv
transfer
antibodi
affect
viral
titer
lower
respiratori
tract
determin
qrtpcr
fig
rabbit
receiv
undilut
passiv
transfer
pt
serum
exhibit
immunopatholog
similar
observ
previous
infect
rabbit
base
blind
score
fig
tabl
increas
observ
vascular
congest
group
merscov
n
protein
right
follow
reinfect
tcid
reinfect
group
b
e
tcid
reinfect
group
c
f
tcid
media
control
group
includ
demonstr
observ
inflamm
residu
primari
infect
g
n
rabbit
per
group
imag
bar
equival
inset
bar
equival
imag
day
postinfect
pt
rabbit
compar
group
rabbit
receiv
serum
antibodi
lower
dilut
demonstr
enhanc
inflamm
fig
tabl
overal
patholog
rabbit
infect
pt
postinfect
serum
milder
reinfect
studi
possibl
due
shorten
interv
primari
infect
reinfect
viral
antigen
level
appear
similar
group
ihc
fig
tabl
enhanc
inflamm
mer
reinfect
rabbit
increas
complement
activ
associ
enhanc
inflamm
nonneutr
antibodi
typic
enhanc
inflamm
patholog
immun
respons
interact
fc
complement
receptor
first
examin
possibl
antibodi
caus
enhanc
inflamm
due
increas
viral
uptak
replic
macrophag
interact
nativ
cellular
receptor
fc
receptor
happen
dengu
antibodydepend
enhanc
ade
infect
also
observ
coronavirus
felin
infecti
periton
viru
fipv
howev
clear
mechan
like
sinc
enhanc
inflamm
secondari
merscov
infect
rabbit
associ
increas
viral
load
either
qrtpcr
ihc
fig
tabl
order
examin
replic
merscov
macrophag
differenti
cell
macrophag
infect
merscov
presenc
absenc
rabbit
sera
measur
viral
titer
hour
heatinactiv
sera
rabbit
week
week
follow
primari
infect
nonneutr
antibodi
present
week
follow
secondari
infect
neutral
antibodi
present
test
three
dilut
dilut
display
similar
trend
undilut
sampl
shown
fig
cell
use
posit
control
fig
raji
cell
includ
neg
control
fig
infect
compar
level
viral
replic
observ
macrophag
without
serum
addit
rabbit
sera
produc
enhanc
viral
replic
fact
presenc
rabbit
sera
signific
decreas
viral
replic
cell
compar
titer
absenc
rabbit
serum
fig
indic
nonneutr
antibodi
enhanc
merscov
replic
cell
possibl
ade
inflamm
interact
complement
receptor
investig
potenti
role
complement
enhanc
pulmonari
inflamm
evalu
lung
sampl
primari
secondari
merscov
infect
elisa
rabbit
complement
protein
use
assay
observ
increas
amount
complement
protein
per
gram
lung
tissu
secondari
infect
group
mean
ngg
ngg
compar
primari
infect
mean
valu
ngg
fig
increas
signific
group
compar
primari
infect
p
valid
associ
complement
increas
inflamm
use
anticompl
antibodi
immunofluoresc
reveal
complement
recruit
deposit
viru
antigen
within
inflammatori
milieu
surround
mani
vessel
airway
lung
reinfect
rabbit
fig
direct
contrast
primari
infect
group
viru
antigen
detect
adjac
small
vessel
airway
minim
inflamm
evid
complement
deposit
fig
stain
complement
target
unsuccess
rabbit
tissu
enhanc
inflamm
mer
reinfect
rabbit
sinc
cell
respons
could
also
involv
enhanc
inflamm
stain
lung
tissu
antibodi
fig
follow
reinfect
observ
substanti
increas
number
cell
lung
compar
primari
infect
fig
cell
distribut
area
viru
antigen
larg
area
immedi
surround
vessel
airway
fig
attempt
character
cell
unsuccess
merscov
abl
caus
sever
diseas
lethal
outcom
mani
otherwis
healthi
individu
display
mild
asymptomat
diseas
cours
use
rabbit
model
enhanc
inflamm
mer
reinfect
rabbit
examin
serum
respons
follow
asymptomat
infect
found
antibodi
respons
lack
neutral
activ
protect
reinfect
studi
extend
previous
publish
inform
rabbit
model
examin
dose
respons
explor
enhanc
inflamm
observ
reinfect
inclus
low
dose
viru
studi
reveal
potenti
detriment
effect
nonneutr
antibodi
demonstr
protect
benefit
neutral
antibodi
knowledg
rabbit
infect
model
describ
model
merscov
infect
nonneutr
antibodi
exclus
elicit
follow
primari
infect
observ
rabbit
gener
agreement
report
haagman
et
al
except
neutral
antibodi
detect
follow
primari
infect
studi
like
consequ
differ
rout
inocul
haagman
colleagu
inocul
rabbit
intranas
intratrach
rout
enhanc
inflamm
mer
reinfect
rabbit
wherea
studi
rabbit
inocul
intranas
rout
alon
addit
volum
inoculum
state
haagman
et
al
although
recent
public
indic
volum
may
deliv
intratrach
differ
significantli
volum
use
studi
may
affect
viral
load
differ
inocul
rout
volum
shown
affect
diseas
sever
immun
respons
model
lack
neutral
antibodi
rabbit
model
allow
us
examin
phenomenon
otherwis
observ
human
potenti
clinic
implic
find
risk
sever
pulmonari
diseas
person
fail
develop
neutral
antibodi
respons
follow
exposur
merscov
person
titer
neutral
antibodi
decay
longer
detect
rabbit
highest
mean
viral
rna
level
observ
lower
respiratori
tract
report
human
case
direct
correl
observ
distribut
amount
viral
antigen
inflamm
lung
rabbit
limit
number
sampl
aberrantli
high
level
viral
antigen
observ
qualit
quantit
measur
mirror
qrtpcr
result
tabl
believ
occur
due
sampl
locat
inoculum
pool
infect
particularli
sinc
atyp
valu
occur
often
caudal
lobe
cellular
infiltr
observ
rabbit
lung
larg
compos
mix
popul
eosinophil
histiocyt
mammalian
speci
presenc
eosinophil
inflamm
often
associ
parasit
infect
hypersensit
reaction
less
often
certain
fungal
infect
evid
parasit
fungal
infect
rabbit
commonli
observ
featur
hypersensitivityrel
pneumon
ie
edema
bronchiol
absent
viral
replic
upper
respiratori
tract
detect
primari
infect
suggest
immun
respons
prevent
local
replic
viru
later
challeng
analyz
serum
igg
antibodi
elisa
mucos
iga
antibodi
upper
respiratori
tract
may
also
play
role
prevent
reinfect
howev
serum
igg
antibodi
lack
neutral
activ
contribut
enhanc
pulmonari
inflamm
observ
upon
reinfect
passiv
transfer
serum
previous
infect
rabbit
anim
follow
merscov
challeng
recreat
histopatholog
depict
though
increas
vascular
congest
follow
passiv
transfer
observ
previous
infect
rabbit
like
consequ
transfer
complet
serum
contain
addit
serum
protein
includ
involv
complement
cascad
rabbit
instead
transfer
purifi
merscov
specif
igg
antibodi
observ
studi
addit
complement
protein
could
led
increas
inflamm
congest
lung
even
presenc
enhanc
inflamm
follow
reinfect
rabbit
continu
lack
discern
clinic
sign
infect
occurr
could
explain
sever
factor
rabbit
prey
anim
evolv
mask
sign
ill
defens
mechan
also
experi
conduct
high
contain
facil
limit
abil
measur
activ
level
furthermor
lesion
lung
typic
multifoc
focal
sever
remain
lung
tissu
may
suffici
function
limit
clinic
sign
effect
nonneutr
antibodi
observ
merscov
studi
differ
observ
fipv
flavivirus
dengu
sinc
nonneutr
antibodi
enhanc
merscov
replic
enhanc
inflamm
observ
rabbit
merscov
reinfect
appear
mediat
interact
nonneutr
antibodi
complement
protein
result
activ
complement
cascad
format
immun
complex
increas
protein
rabbit
lung
follow
reinfect
support
possibl
immun
complex
implic
pathogenesi
viral
infect
includ
influenza
rsv
format
membran
attack
complex
mac
typic
involv
respons
bacteri
pathogen
envelop
virus
also
suscept
lysi
mac
complement
activ
also
respons
increas
releas
anaphylotoxin
recruit
activ
immun
cell
lead
inflamm
presenc
cell
region
lung
merscov
n
antigen
reinfect
consist
scenario
fig
studi
demonstr
merscov
reinfect
elicit
neutral
antibodi
protect
rabbit
viral
challeng
antibodymedi
protect
also
exhibit
rabbit
mice
follow
prophylaxi
neutral
monoclon
antibodi
merscov
spike
protein
data
support
induct
neutral
antibodi
primari
goal
vaccin
howev
use
convalesc
serum
treatment
merscov
infect
individu
limit
benefit
also
past
experi
sarscov
trigger
cautionari
note
mous
hamster
model
vaccineinduc
neutral
antibodi
prevent
reduc
replic
sarscov
contrast
ferret
nonhuman
primat
model
sarscov
antibodi
restrict
replic
challeng
viru
prevent
pulmonari
inflamm
addit
antibodydepend
enhanc
pulmonari
immunopatholog
seen
follow
challeng
vaccin
strategi
sarscov
includ
viruslik
particl
inactiv
vaccin
data
suggest
merscov
vaccin
approach
may
also
result
immunopatholog
eosinophil
infiltr
enhanc
lung
patholog
observ
vaccin
transgen
mice
follow
merscov
challeng
sinc
mice
neutral
antibodi
challeng
signific
reduct
viral
titer
follow
challeng
compar
control
mice
believ
mechan
behind
two
phenomena
distinct
still
requir
consider
discrep
observ
highlight
critic
need
addit
clinic
data
continu
attent
develop
test
coronaviru
vaccin
anoth
approach
view
data
consid
primari
infect
rabbit
type
vaccin
result
immun
respons
without
overt
clinic
symptom
prime
infect
produc
immun
respons
inadequ
protect
secondari
infect
act
booster
activ
memori
respons
elicit
primari
infect
induc
neutral
antibodi
either
interpret
indic
product
neutral
antibodi
goal
merscov
vaccin
addit
vaccin
dose
may
need
neutral
antibodi
titer
wane
rapidli
rare
case
qrtpcr
confirm
human
merscov
infect
report
neutral
protein
elisa
antibodi
respons
detect
often
follow
mild
asymptomat
infect
rabbit
model
particularli
use
lower
viral
inoculum
dose
volum
may
recapitul
case
neutral
antibodi
merscov
produc
wane
time
mild
asymptomat
infect
may
prime
individu
sever
diseas
upon
reexposur
possibl
could
occur
either
infect
vaccin
consid
develop
merscov
vaccin
cell
atcc
grown
maintain
optimem
media
gibco
fb
hyclon
raji
atcc
cell
atcc
maintain
media
gibco
fb
sigma
viru
obtain
erasmu
medic
center
netherland
viru
stock
store
titer
stock
viru
determin
serial
dilut
cell
calcul
reed
muench
method
experi
perform
biosafeti
level
facil
male
new
zealand
white
rabbit
covanc
princeton
nj
five
nine
month
age
anesthet
combin
intramuscular
dexmedetomidin
isofluran
inhal
anim
inocul
intranas
viru
dilut
merscov
media
gibco
mockinfect
media
alon
atipamezol
subsequ
administ
subcutan
revers
sedat
rabbit
monitor
daili
day
infect
clinic
sign
diseas
includ
temperatur
weight
lethargi
ocular
discharg
rhiniti
labor
breath
ruffl
fur
inappet
diarrhea
serum
collect
via
ear
vein
prior
inocul
specifi
time
follow
infect
anim
euthan
beuthanasia
administr
tissu
collect
viral
titrat
histopatholog
immunohistochemistri
ihc
passiv
transfer
pt
studi
serum
rabbit
infect
day
prior
concentr
use
amicon
filter
column
transfer
intraven
ear
vein
rabbit
either
undilut
dilut
one
day
prior
infect
tcid
mer
cov
infect
consist
strain
unless
otherwis
note
anim
studi
conduct
laboratori
nation
institut
health
nih
procedur
review
approv
niaid
dir
anim
care
use
committe
anim
hous
rabbitferret
biocontain
rack
maintain
accord
anim
welfar
act
guid
care
use
laboratori
anim
feder
statut
regul
relat
anim
fulli
aaalac
accredit
facil
procedur
perform
util
appropri
anesthet
list
niaid
dir
anim
care
use
committe
approv
anim
studi
propos
lid
euthanasia
method
consist
avma
guidelin
euthanasia
endpoint
criteria
list
niaid
dir
anim
care
use
committe
approv
anim
studi
propos
lid
niaid
dir
anim
care
use
program
part
nih
intramur
research
program
irp
compli
applic
provis
anim
welfar
act
http
wwwaphisusdagovanimalwelfaredownloadsawaawapdf
feder
statut
regul
relat
anim
niaid
dir
anim
care
use
program
guid
us
govern
principl
util
care
vertebr
anim
use
test
research
train
http
oacuodnihgovregsusgovtprncplhtm
niaid
dir
anim
care
use
program
acknowledg
accept
respons
care
use
anim
involv
activ
cover
nih
irp
ph
assur
last
issu
partial
fulfil
respons
niaid
dir
anim
care
use
program
ensur
individu
involv
care
use
laboratori
anim
understand
individu
collect
respons
complianc
assur
well
applic
law
regul
pertain
anim
care
use
niaid
dir
anim
care
use
program
establish
maintain
program
activ
involv
anim
accord
recent
th
edit
guid
care
use
laboratori
anim
ilar
nrc
http
oacuodnih
polici
procedur
guidelin
nih
irp
explicitli
detail
nih
polici
manual
anim
care
use
intramur
program
pm
nih
anim
research
advisori
committe
guidelin
arac
guidelin
document
post
nih
offic
anim
care
use
public
websit
http
oacuodnihgov
lung
nasal
turbin
collect
viral
titrat
store
process
tissu
weigh
homogen
media
contain
antibioticantimycot
invitrogen
final
wtvol
homogen
centrifug
minut
rpm
swing
bucket
rotor
sorval
viral
rna
isol
homogen
use
qiamp
viral
rna
mini
kit
qiagen
follow
manufactur
instruct
qrtpcr
reaction
amplifi
use
rna
per
reaction
primer
set
design
detect
merscov
via
viral
envelop
upe
nucleocapsid
protein
superscript
iii
platinum
onestep
qrtpcr
kit
life
technolog
result
display
use
primer
confirmatori
primer
set
sampl
rabbit
alway
run
verifi
background
detect
primer
set
standard
dilut
set
titer
viru
stock
run
parallel
sampl
test
duplic
titer
express
log
tcid
equival
per
gram
tissu
lung
tissu
sampl
lobe
resect
formalinfix
tissu
tissu
embed
paraffin
section
stain
hematoxylin
eosin
histoserv
germantown
maryland
section
examin
light
microscopi
lm
fluoresc
microscopi
fm
use
olympu
microscop
photomicrograph
taken
use
olympu
lm
camera
camera
fm
histopatholog
score
tissu
blind
lung
section
bake
hour
paraffin
remov
xylen
sampl
rehydr
alcoholgrad
wash
section
microwav
antigen
unmask
solut
vector
laboratori
expos
protein
block
dako
minut
immunohistochemistri
ihc
mous
antim
nucleocapsid
protein
np
antibodi
biorbyt
ad
dilut
follow
biotinyl
hors
antimous
immunoglobulin
g
igg
vector
laboratori
dilut
rat
abd
serotec
dilut
goat
r
system
dilut
antibodi
follow
hydrogen
peroxid
block
step
endogen
peroxidas
activ
respect
biotinyl
goat
antirat
hors
antigoat
igg
antibodi
vector
laboratori
dilut
detect
mer
np
complet
incub
minut
vectastain
abcap
reagent
vector
laboratori
minut
vulcan
fast
red
biocar
detect
complet
incub
minut
vectastain
abc
rtu
vector
laboratori
minut
dab
immunofluoresc
antibodi
assay
ifa
differenti
primari
antibodi
incub
complement
antibodi
mybiosourc
ad
dilut
follow
goat
antiguinea
pig
igg
vector
laboratori
streptavidin
conjug
alexafluor
life
technolog
mer
np
ihc
detect
goat
antimous
directli
conjug
alexafluor
dilut
slide
counterstain
hematoxylin
ihc
dapi
ifa
evalu
veterinari
pathologist
imag
analysi
perform
merscov
infect
lung
tissu
provid
quantit
analysi
mer
viru
antigen
present
lung
associ
inflammatori
respons
follow
histolog
hematoxylin
eosin
h
e
immunohistochem
evalu
lung
section
tissu
slide
digit
brightfield
leica
aperio
slide
scanner
magnif
fig
imag
evalu
use
webbas
digit
patholog
inform
manag
system
eslid
manag
use
digit
slide
view
imag
analysi
aperio
posit
pixel
count
ppc
color
deconvolut
base
algorithm
adjust
recogn
inflammatori
region
intens
vulcan
fast
red
chromogen
biocar
medic
respect
previous
stain
scan
lung
section
analysi
base
set
hue
valu
hue
width
ppc
valu
red
blue
green
channel
cd
gate
select
region
interest
prevent
incorpor
nonspecif
stain
result
macro
optim
suit
desir
applic
set
save
use
evalu
slide
channel
paramet
h
e
mersspecif
macro
follow
neutral
activ
rabbit
sera
evalu
microneutr
mn
assay
determin
antibodi
titer
serial
twofold
dilut
sera
prepar
tcid
viru
mix
sera
equal
volum
incub
one
hour
room
temperatur
mixtur
subsequ
ad
quadrupl
cell
monolay
serum
neutral
titer
determin
reciproc
serum
dilut
neutral
viru
evidenc
absenc
cytopath
effect
day
confirm
day
quantifi
anti
protein
igg
antibodi
rabbit
serum
plate
coat
overnight
recombin
merscov
protein
sino
biolog
sodium
bicarbon
buffer
subsequ
plate
block
hour
room
temperatur
fb
pb
plate
wash
incub
hour
serial
fourfold
dilut
heatinactiv
rabbit
serum
duplic
plate
wash
incub
room
temp
hrp
conjug
goat
antirabbit
igg
abcam
dilut
pb
bsa
detect
follow
addit
wash
sureblu
tmb
microwel
peroxidas
substrat
kpl
ad
well
tmb
bluestop
solut
kpl
ad
minut
optic
densiti
well
measur
nm
spectramax
plate
reader
molecular
devic
od
greater
two
standard
deviat
mean
background
consid
posit
examin
antin
protein
igg
antibodi
rabbit
serum
util
elisa
protocol
develop
cdc
briefli
plate
coat
overnight
purifi
merscov
n
antigen
irrelev
control
antigen
obtain
divis
viral
diseas
center
diseas
control
prevent
pb
plate
wash
serial
fourfold
dilut
heatinactiv
rabbit
serum
ad
one
hour
incub
plate
wash
incub
hrp
conjug
goat
antirabbit
igg
abcam
dilut
pb
bsa
one
hour
follow
addit
wash
posit
sera
determin
addit
abt
peroxidas
substrat
solut
kpl
incub
minut
follow
addit
abt
stop
solut
kpl
optic
densiti
well
measur
nm
spectramax
plate
reader
molecular
devic
od
neg
control
consid
posit
compar
amount
present
rabbit
lung
follow
infect
merscov
util
rabbit
complement
fragment
elisa
kit
mybiosourc
accord
manufactur
instruct
frozen
rabbit
lung
sampl
rins
homogen
wv
pb
store
overnight
follow
two
freezethaw
cycl
sampl
centrifug
minut
supernat
assay
immedi
triplic
undilut
sampl
ad
precoat
plate
sampl
remov
biotinantibodi
ad
plate
wash
time
addit
hrpavidin
antibodi
plate
wash
time
incub
tmb
substrat
stop
solut
ad
od
measur
within
minut
sampl
quantit
base
standard
dilut
seri
within
plate
determin
antibodi
result
increas
viral
replic
macrophag
conduct
antibodydepend
enhanc
ade
assay
cell
differenti
macrophag
addit
pma
rpmi
media
hour
follow
week
cultur
without
pma
cell
becam
adher
flask
took
macrophagelik
appear
differenti
cell
confirm
immunofluoresc
loss
increas
cell
surfac
compar
undifferenti
cell
adapt
genin
et
al
posit
control
infect
cell
neg
control
includ
raji
cell
lack
fc
receptor
heatinactiv
rabbit
sera
three
dilut
undilut
incub
moi
hour
addit
onto
cell
type
duplic
plate
hour
cell
wash
incub
hour
supernat
collect
viral
titrat
mean
viral
titer
display
standard
error
mean
statist
signific
determin
use
oneway
anova
multipl
comparison
test
graphpad
prism
